New molecular insights into peripheral T cell lymphomas

Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters

(2012) F. Lemonnier et al.   BLOOD

Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma

(2012) L. Agnelli et al.   BLOOD

IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma

(2012) R. A. Cairns et al.   BLOOD

BCL10 down-regulation in peripheral T-cell lymphomas

(2012) Maura Rossi et al.   HUMAN PATHOLOGY

Type II Enteropathy-Associated T-Cell Lymphoma

(2011) John K.C. Chan et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Intensified alemtuzumab-CHOP therapy for peripheral T-cell lymphoma

(2011) H. C. Kluin-Nelemans et al.   ANNALS OF ONCOLOGY

Oncogenic tyrosine kinase NPM-ALK induces expression of the growth-promoting receptor ICOS

(2011) Q. Zhang et al.   BLOOD

MiR-29a down-regulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression

(2011) C. Desjobert et al.   BLOOD

Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma

(2011) R. L. Piekarz et al.   BLOOD

miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma

(2011) H. Matsuyama et al.   BLOOD

Revising the historical collection of epithelioid cell-rich lymphomas of the Kiel Lymph Node Registry: what is Lennert’s lymphoma nowadays?

(2011) Sylvia Hartmann et al.   HISTOPATHOLOGY

Peripheral T cell lymphomas with follicular T helper phenotype: a new basket or a distinct entity? Revising Karl Lennert’s personal archive

(2011) Claudio Agostinelli et al.   HISTOPATHOLOGY

TCR-dependent transformation of mature memory phenotype T cells in mice

(2011) Xi Wang et al.   JOURNAL OF CLINICAL INVESTIGATION

CEP-28122, a Highly Potent and Selective Orally Active Inhibitor of Anaplastic Lymphoma Kinase with Antitumor Activity in Experimental Models of Human Cancers

(2011) M. Cheng et al.   MOLECULAR CANCER THERAPEUTICS

Foxp3+ follicular regulatory T cells control the germinal center response

(2011) Michelle A Linterman et al.   NATURE MEDICINE

Targeted molecular therapy in peripheral T-cell lymphomas

(2011) Fernando Roncolato et al.   Expert Review of Hematology

Peripheral T-cell lymphoma classification: the matter of cellular derivation

(2011) Pier Paolo Piccaluga et al.   Expert Review of Hematology

Regulatory T-Cell Depletion in Angioimmunoblastic T-Cell Lymphoma

(2010) Julie Bruneau et al.   AMERICAN JOURNAL OF PATHOLOGY

Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing

(2010) A. L. Feldman et al.   BLOOD

Transcriptional Profiles Predict Disease Outcome in Patients with Cutaneous T-Cell Lymphoma

(2010) I. V. Litvinov et al.   CLINICAL CANCER RESEARCH

A novel subset of T-helper cells: follicular T-helper cells and their markers

(2010) C. Laurent et al.   HAEMATOLOGICA

Gene Expression Profiling Uncovers Molecular Classifiers for the Recognition of Anaplastic Large-Cell Lymphoma Within Peripheral T-Cell Neoplasms

(2010) Roberto Piva et al.   JOURNAL OF CLINICAL ONCOLOGY

Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro

(2010) J Iqbal et al.   LEUKEMIA

Evaluation of lymphangiogenic markers in Sézary syndrome

(2010) Maria B. Karpova et al.   LEUKEMIA & LYMPHOMA

Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas

(2010) Anas Younes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma

(2010) O. Merkel et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Platelet-derived growth factor mediates survival of leukemic large granular lymphocytes via an autocrine regulatory pathway

(2009) J. Yang et al.   BLOOD

Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability

(2009) C. A. Pise-Masison et al.   BLOOD

Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type

(2009) Y. Huang et al.   BLOOD

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

(2009) J. Iqbal et al.   BLOOD

Variable CD52 expression in mature T cell and NK cell malignancies: implications for alemtuzumab therapy

(2009) Liuyan Jiang et al.   BRITISH JOURNAL OF HAEMATOLOGY

A Phase II study of SGN-30 (anti-CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma

(2009) Andres Forero-Torres et al.   BRITISH JOURNAL OF HAEMATOLOGY

High resolution SNP array genomic profiling of peripheral T cell lymphomas, not otherwise specified, identifies a subgroup with chromosomal aberrations affecting theRELlocus

(2009) Sylvia Hartmann et al.   BRITISH JOURNAL OF HAEMATOLOGY

Bcl-10 protein highly correlates with the expression of phosphorylated p65 NF-κB in peripheral T-cell lymphomas and is associated with clinical outcome

(2009) Javier Briones et al.   HISTOPATHOLOGY

Inhibition of Syk protein tyrosine kinase induces apoptosis and blocks proliferation in T-cell non-Hodgkin's lymphoma cell lines

(2009) R A Wilcox et al.   LEUKEMIA

CD52 expression in peripheral T-cell lymphomas determined by combined immunophenotyping using tumor cell specific T-cell receptor antibodies

(2009) Eva Geissinger et al.   LEUKEMIA & LYMPHOMA

Gamma-delta T-cell lymphomas

(2009) Claudio Tripodo et al.   Nature Reviews Clinical Oncology

Primary Cutaneous CD4+ Small/Medium-sized Pleomorphic T-cell Lymphoma Expresses Follicular T-cell Markers

(2008) Socorro Maria Rodríguez Pinilla et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Complete response of relapsed angioimmunoblastic T-cell lymphoma following therapy with bevacizumab

(2008) D. Aguiar Bujanda   ANNALS OF ONCOLOGY

International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes

(2008)   JOURNAL OF CLINICAL ONCOLOGY

Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies

(2008) C Agostinelli et al.   JOURNAL OF CLINICAL PATHOLOGY

Complete remission induced by thalidomide in a case of angioimmunoblastic T-cell lymphoma refractory to autologous stem cell transplantation

(2008) Michele Gottardi et al.   LEUKEMIA & LYMPHOMA

The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination

(2008) Roberto Chiarle et al.   NATURE MEDICINE